Sophysa is a global supplier of neurosurgical devices. Founded in 1976, Sophysa designs, manufactures, and distributes a portfolio of implantable micromechanisms, with an intense focus on the management of CSF fluid and related disorders.
Based in Besançon, the engineering epicenter of France, Sophysa has been a pioneer in the creation and enhanced development of adjustable shunting technologies, integrated intracranial monitoring, and intrathecal access, while also providing innovative cranial fixation, electrosurgical, and trepanation tools.
Sophysa's products include the following fully complemented families:
• Polaris® - world's first MR-stable adjustable CSF valve, in 2004
• Pressio® - industry-leading neurocritical monitoring, since 2005
A member of the TKB Group since 1989, Sophysa has an expanding international footprint, with local representation in more than 70 countries, ISO certification, GSl compliance, and good standing with all notified regulatory bodies.
Sophysa's mission is vitality for all, providing safe, effective, and economical solutions, with sophisticated simplicity - at the heart of the brain.